Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP412645.RALVLWtBmg_X6j43_P6Q9z-UHVY24vD7H8e5_cXQbYdk4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP412645.RALVLWtBmg_X6j43_P6Q9z-UHVY24vD7H8e5_cXQbYdk4130_assertion type Assertion NP412645.RALVLWtBmg_X6j43_P6Q9z-UHVY24vD7H8e5_cXQbYdk4130_head.
- NP412645.RALVLWtBmg_X6j43_P6Q9z-UHVY24vD7H8e5_cXQbYdk4130_assertion description "[The phenotype HP1 was found to have an increased incidence in the total patient group due to an increased incidence in those with AML, ALL and CML compared with controls, but not in those with CLL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP412645.RALVLWtBmg_X6j43_P6Q9z-UHVY24vD7H8e5_cXQbYdk4130_provenance.
- NP412645.RALVLWtBmg_X6j43_P6Q9z-UHVY24vD7H8e5_cXQbYdk4130_assertion evidence source_evidence_literature NP412645.RALVLWtBmg_X6j43_P6Q9z-UHVY24vD7H8e5_cXQbYdk4130_provenance.
- NP412645.RALVLWtBmg_X6j43_P6Q9z-UHVY24vD7H8e5_cXQbYdk4130_assertion SIO_000772 3397067 NP412645.RALVLWtBmg_X6j43_P6Q9z-UHVY24vD7H8e5_cXQbYdk4130_provenance.
- NP412645.RALVLWtBmg_X6j43_P6Q9z-UHVY24vD7H8e5_cXQbYdk4130_assertion wasDerivedFrom befree-20140225 NP412645.RALVLWtBmg_X6j43_P6Q9z-UHVY24vD7H8e5_cXQbYdk4130_provenance.
- NP412645.RALVLWtBmg_X6j43_P6Q9z-UHVY24vD7H8e5_cXQbYdk4130_assertion wasGeneratedBy ECO_0000203 NP412645.RALVLWtBmg_X6j43_P6Q9z-UHVY24vD7H8e5_cXQbYdk4130_provenance.